Suitable for solutions that require high flow rates, high filtration volumes, and low protein adsorption! Extends filtration lifespan.
The "AcroPak Capsule Filter - Supor Membrane" is suitable for solutions that require high flow rates, high filtration capacity, and low protein adsorption. The lineup includes "AcroPak 20 - Supor," "AcroPak 200 - Supor," and "AcroPak 500, 1000, 1500 - Supor." The built-in pre-filter extends the filtration lifespan when processing high-viscosity solutions or solutions containing a large number of fine particles (such as media containing serum). 【Lineup】 ■ AcroPak 20 - Supor ■ AcroPak 200 - Supor ■ AcroPak 500, 1000, 1500 - Supor *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【AcroPak 20・Supor Features】 ■ Efficiently processes chemicals and biological fluids up to 2 L ■ The air vent on the primary side prevents vapor lock ■ The built-in pre-filter extends the filtration life when processing high-viscosity solutions and solutions containing many fine particles (such as media containing serum) *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Application】 <AcroPak 20・Supor> ■ Designed to accommodate small and medium volume filtration (sterilization and non-sterilization) ■ Suitable for use with solutions containing low concentration proteins, preservatives, and other critical components ■ Filtration of culture media and buffers <AcroPak 200・Supor> ■ Filtration sterilization for small to medium batch sizes ■ Suitable for use with solutions containing low concentration proteins, preservatives, and other critical components ■ Filtration of culture media and buffers ■ On-demand filtration of water used in laboratories <AcroPak 500・1000・1500・Supor> ■ Large volume media preparation ■ Pilot testing of manufacturing processes ■ Solutions requiring pre-filtration, such as media containing serum ■ Filtration of water used in laboratories ■ Mycoplasma removal with a pore size of 0.1 μm *For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
